Status:
COMPLETED
Transradial Selective Catheterization of the Celiac Artery in Obese Patients
Lead Sponsor:
Laval University
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
BACKGROUND: * Obesity, with its associated comorbidities, is set to become a major risk factor for cardiovascular disease in the 21st century. To this day, diet and medical therapy have proven only l...
Detailed Description
RATIONALE: * A significant proportion of patients referred to IUCPQ-UL catheterization laboratory are overweight (body mass index \>25 kg/m²). * Ongoing research and early clinical experience suggest...
Eligibility Criteria
Inclusion
- Patients undergoing coronary angiography with a BMI \>30 kg/m² will be eligible.
Exclusion
- Kidney disease defined by a glomerular filtration rate less than 60 ml/min/m² according to the Modification of Diet in Renal Disease (MDRD) formula;
- Previous gastric or bariatric surgery;
- Emergency coronary procedure.
- Furthermore, the procedure will be cancelled if one of the following criteria are met during the coronary angiography:
- Contrast volume \>250 ml;
- Radiation dose \>180 Gy.cm² as assessed by the dose area product (DAP).
Key Trial Info
Start Date :
February 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT03434665
Start Date
February 9 2018
End Date
September 30 2019
Last Update
November 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Quebec Heart & Lung Institute (IUCPQ-UL)
Québec, Quebec, Canada, G1V 4G5